Concepedia

Donald J. Skalitzky

DJ

20

Publications

2.1K

Citations

17

H-Index

1989

Active since

Affiliations

Pfizer (United States)(Current)

Newcastle University

University of California, Irvine

University of Minnesota

Donald J. Skalitzky is an author at Pfizer (United States) specializing in organic chemistry, pharmacology, and chemistry.

Top concepts

Publications per year

1989–2021

20

Publications

20

Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361

Christopher Calabrese, Robert J. Almassy, Stephen Barton et al. · JNCI Journal of the National Cancer Institute · 2004 · 482 citations · Full text

Stereochemistry of alternating polyol chains: 13C NMR analysis of 1,3-diol acetonides

Scott D. Rychnovsky, Donald J. Skalitzky · Tetrahedron Letters · 1990 · 477 citations

, , +8

Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial

Huw D. Thomas, Christopher Calabrese, Michael A. Batey et al. · Molecular Cancer Therapeutics · 2007 · 297 citations

Tricyclic Benzimidazoles as Potent Poly(ADP-ribose) Polymerase-1 Inhibitors

Donald J. Skalitzky, Joseph Marakovits, Karen A. Maegley et al. · Journal of Medicinal Chemistry · 2002 · 152 citations · Full text

, , +13

Optically pure 1,3-diols from (2R,4R)- and (2S,4S)-1,2:4,5-diepoxypentane

Scott D. Rychnovsky, George Griesgraber, Sam Zeller et al. · The Journal of Organic Chemistry · 1991 · 107 citations

, , +12

Rows per page

1–5 of 20